$ARTH flag $0.41 Multi bagger corrected Called 1
Post# of 63688
Multi bagger corrected
Called 12/31/13 $033.
Website
ares Outstanding: 116.83M
Float: 88.87M
% Held by Insiders: N/A
% Held by : N/A
Headlines
Arch Therapeutics, Inc. operates as a life science medical device company. The company focuses on developing products based on a novel technology to stop bleeding and control leaking during surgery and trauma care. Its lead product candidate is AC5 Surgical Hemostatic Device, a biocompatible synthetic peptide comprising naturally occurring amino acids to achieve hemostasis in minimally invasive and open surgical procedures. The company was founded in 2006 and is based in Framingham, Massachusetts.